| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.0008 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.002 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |